Time from last immunity event against infection during Omicron-dominant period in Malaysia

Int J Infect Dis. 2023 Mar:128:98-101. doi: 10.1016/j.ijid.2022.12.025. Epub 2022 Dec 26.

Abstract

Objectives: To study the incidence of Omicron infections in Malaysia and the exposures that could reduce the hazard of attaining Omicron infection.

Methods: We used a multicenter, prospective cohort to study 482 healthcare workers vaccinated with two and three doses of BNT162b2 for SARS-CoV-2 infection during the Omicron-dominant period in Malaysia.

Results: Between January 31 and July 31, 2022, the cumulative incidence was 44.6% (95% CI 40.2-49.1%), and the incidence rate was 3.33 (95% CI 2.91-3.80) per 1000 person-days. Our study found that protection against Omicron infection was significantly higher for persons with previous SARS-CoV-2 infection (hazard ratio [HR] 0.41, 95% CI 0.27-0.62) and persons with a more recent immunity event (<30 days [reference] vs >90 days, HR 3.82, 95%CI 1.34-10.90) from the beginning of the Omicron period.

Conclusion: Pre-Omicron natural infection and a recent immunity event protect against future Omicron infections.

Keywords: Healthcare workers; Hybrid immunity; Malaysia; Omicron; Previous SARS-CoV-2 infection; Vaccination.

Publication types

  • Multicenter Study

MeSH terms

  • BNT162 Vaccine*
  • COVID-19*
  • Humans
  • Malaysia
  • Prospective Studies
  • SARS-CoV-2

Substances

  • BNT162 Vaccine